Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 61 AL 75

Hydrocephalus with Hirschsprung disease: severe end of X-linked hydrocephalus spectrum

Takenouchi T, Nakazawa M, Kanemura Y, Shimozato S, Yamasaki M, Takahashi T, Kosaki K.

Am J Med Genet A. 2012 Apr;158A(4):812-5. doi: 10.1002/ajmg.a.35245. Epub 2012 Feb 21.

[New knowledge of spasticity and its treatment]

Lorentzen J, Willerslev-Olsen M, Crone C, Sinkjær T, Nielsen JB.

Ugeskr Laeger. 2012 Feb 27;174(9):569-73.

Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial

Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.

Neurorehabil Neural Repair. 2012 Sep;26(7):812-21. doi: 10.1177/1545968311430824. Epub 2012 Feb 27.

Intensive aerobic cycling training with lower limb weights in Chinese patients with chronic stroke: discordance between improved cardiovascular fitness and walking ability

Jin H, Jiang Y, Wei Q, Wang B, Ma G.

Disabil Rehabil. 2012;34(19):1665-71. doi: 10.3109/09638288.2012.658952. Epub 2012 Mar 1.

Pilot comparative study of unilateral and bilateral robot-assisted training on upper-extremity performance in patients with stroke

Yang CL, Lin KC, Chen HC, Wu CY, Chen CL.

Am J Occup Ther. 2012 Mar-Apr;66(2):198-206. doi: 10.5014/ajot.2012.003103.

Anti-spastic effects of the direct application of vibratory stimuli to the spastic muscles of hemiplegic limbs in post-stroke patients: a proof-of-principle study

Noma T, Matsumoto S, Shimodozono M, Etoh S, Kawahira K.

J Rehabil Med. 2012 Apr;44(4):325-30. doi: 10.2340/16501977-0946.

Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects

Gessain A, Mahieux R.

Rev Neurol (Paris). 2012 Mar;168(3):257-69. doi: 10.1016/j.neurol.2011.12.006. Epub 2012 Mar 7.

Botulinum toxin A in prostate disease: a venom from bench to bed-side

Mearini L, Giannantoni A.

Curr Drug Deliv. 2012 Jan;9(1):85-94. doi: 10.2174/156720112798375970.

Recognition and diagnosis of neuro-ichthyotic syndromes

Rizzo WB, Jenkens SM, Boucher P.

Semin Neurol. 2012 Feb;32(1):75-84. doi: 10.1055/s-0032-1306390. Epub 2012 Mar 15.

Neural tension technique is no different from random passive movements in reducing spasticity in patients with traumatic brain injury

Lorentzen J, Nielsen D, Holm K, Baagøe S, Grey MJ, Nielsen JB.

Disabil Rehabil. 2012;34(23):1978-85. doi: 10.3109/09638288.2012.665132. Epub 2012 Mar 19.

Botulinum toxin type A for the treatment of equinus deformity in patients with mucopolysaccharidosis type II

Nava E, Weber P, Gautschi M, Nuoffer JM, Grunt S.

J Child Neurol. 2012 Dec;27(12):1611-5. doi: 10.1177/0883073812438100. Epub 2012 Mar 20.

Evidence to practice: botulinum toxin in the treatment of spasticity post stroke

Teasell R, Foley N, Pereira S, Sequeira K, Miller T.

Top Stroke Rehabil. 2012 Mar-Apr;19(2):115-21. doi: 10.1310/tsr1902-115.

Contribution of ankle dorsiflexor strength to walking endurance in people with spastic hemiplegia after stroke

Ng SS, Hui-Chan CW.

Arch Phys Med Rehabil. 2012 Jun;93(6):1046-51. doi: 10.1016/j.apmr.2011.12.016. Epub 2012 Mar 20.

Effect of topical anesthetics on needle insertion pain during botulinum toxin type A injections for limb spasticity

Fung S, Phadke CP, Kam A, Ismail F, Boulias C.

Arch Phys Med Rehabil. 2012 Sep;93(9):1643-7. doi: 10.1016/j.apmr.2012.03.012. Epub 2012 Mar 23.

Extract from Cannabis sativa -- Benefit Assessment According to §35a Social Code Book V

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2012 Mar 29. Extract of Dossier Assessment No. A12-01.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias